FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

enGene Therapeutics Inc.: accounts_payable

One fact, its scope and the complete path back to the official record.

Period: as of 2025-10-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/e09dff73-7b54-44b6-b5dd-5b17e754a62a

Reported value

$6.688M{"amount": 6688000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"}
Entity
enGene Therapeutics Inc.
Metric
accounts_payable
Period
as of 2025-10-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-25-328743 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T19:02:21.808587+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001980845/accounts-payable/2025-10-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.